USPTO serial 79382010
BBOS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BURRUS, JESSICA E
- Law office
- TMO LAW OFFICE 121
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BBOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological agents (bacterial, fungal or other fungicides, weedkillers, herbicides, insecticides, parasiticides, pesticides); biological control agents; biological preparations for medical purposes; biological preparations for pharmaceutical purposes; biological preparations for use in biotechnology (medical); biological preparations for use in cell cultures (medical); biological products for medical use; biological substances for medical use; biological tissue cultures for medical purposes; reagents for use in biological processing (for medical purposes); bacteriological culture mediums; bacteriological cultures for medical and veterinary use; bacteriological preparations for medical and veterinary use; testing reagents for medical use in detecting allergenic substances; capsules for pharmaceutical purposes; pharmaceutical preparations in the form of tablets; medicines in tablet form; none of the foregoing relating to bepotastine besilate ophthalmic solution or the treatment of ocular itching associated with allergic conjunctivitis (AC); all of the foregoing relating to microbiome based products and therapies and the treatment and prevention of disease by restoring gut microbial ecology | ACTIVE | — |
| 042 | Biological research; bacteriological research; biotechnology testing; biochemistry research services; biotechnology research; biotechnological research; research relating to biotechnology; genetic research; medical research; preparation of reports relating to technical research; conducting statistical scientific studies; pharmaceutical research services; rental of research facilities; research and development of new products for others; research to develop new products; research relating to bacteriology; advisory services relating to technological research; technological research; provision of scientific information; advisory services relating to scientific research; medical research (scientific research for medical purposes); preparation of reports relating to scientific research; analysis of statistical data for scientific research; scientific research into the development of new products; scientific research relating to bacteriology; scientific research relating to biology; scientific research relating to genetics; providing information, including online, about scientific and technological services and research and design relating thereto; provision of information relating to scientific research; scientific research; laboratory analysis; laboratory services (scientific research or analysis); product analysis; scientific and technical analysis; none of the foregoing relating to bepotastine besilate ophthalmic solution or the treatment of ocular itching associated with allergic conjunctivitis (AC); all of the foregoing relating to microbiome based products and therapies and the treatment and prevention of disease by restoring gut microbial ecology | ACTIVE | — |
| 044 | Advisory services relating to medical services; alternative medical services; providing medical services for charitable purposes; gastroenterology (medical services); medical diagnostic services (testing and analysis); advisory services relating to medical problems; advisory services relating to health; health assessment services; health care consultancy services (medical); none of the foregoing relating to bepotastine besilate ophthalmic solution or the treatment of ocular itching associated with allergic conjunctivitis (AC); all of the foregoing relating to microbiome based products and therapies and the treatment and prevention of disease by restoring gut microbial ecology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 22, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 7, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 7, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 25, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 7, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 7, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 14, 2024 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jul 19, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 15, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 24, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 24, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 5, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 5, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 17, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |